China Unicom, YunHuan Technology and ZTE win the GSMA GLOMO "Best Mobile Innovation for Cities" award
BARCELONA, Spain, March 6, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, together with China Unicom and YunHuan Technology, has been awarded the "Best Mobile Innovation for Cities" for their innovative "5G-A Smart City Low-Altitude Blood Delivery" project at the Global Mobile (GLOMO) Awards during MWC Barcelona 2025. The award recognizes their joint efforts in pioneering the commercial deployment of 5G-A Integrated Sensing and Communication technology in urban blood delivery.
To address the challenges of traditional blood delivery, such as traffic congestion and delayed emergency response, the partners have implemented an innovative drone-based solution in Anyang City. The project covers a 1,200-square-kilometer urban airspace, featuring 10 delivery routes that extend over 15 kilometers and serve multiple hospitals across the city. With over 50 flights operating daily, it has become the industry's largest low-altitude drone delivery network for medical supplies, transporting blood products, laboratory samples, pathological sections, emergency medicines, and surgical supplies.
Operational data demonstrates remarkable improvements, with the average blood delivery time reduced from 40 minutes to 15 minutes, representing a 60% efficiency increase. This improvement directly enhanced hospital emergency response, optimized surgery scheduling, and reduced blood wastage, resulting in a 20% decrease in hospital blood costs and 10% reduction in patient blood expenses, delivering significant medical-economic and social benefits.
The solution leverages 5G-A Integrated Sensing and Communication technology to provide capability of comprehensive communication support and safety sensing for drone operations. Network performance tests have proven the system's capability to simultaneously monitor multiple drones' precise positions and flight status with zero detection miss rate, validating the commercial value of 5G-A Integrated Sensing and Communication technology in low-altitude economics.
Looking ahead, the three partners will continue to expanding 5G-A applications in urban management and emergency response, driving the development of low-altitude economy and bringing new momentum to global smart city initiatives.
The annual GLOMO Awards represents the industry's most prestigious accolade. With a judge panel comprising over 260 global analysts, media professionals, and industry experts this year, the GLOMO Awards 2025 celebrates individuals and companies that drive innovation and showcase excellence in the rapidly growing mobile industry.
MEDIA INQUIRIES:ZTE CorporationCommunicationsEmail: ZTE.press.release@zte.com.cn
SOURCE ZTE Corporation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
4 hours ago
- USA Today
Wildfire smoke, shark pardons and lost 401(k) accounts: Your week in review
Wildfire smoke, shark pardons and lost 401(k) accounts: Your week in review Show Caption Hide Caption Smoke drifting into US from Canada wildfires could impact health Smoke from wildfires in Canada has drifted into Montana, the Dakotas, Minnesota, Midwestern and East Coast states, and as far south as Florida. Canadian wildfire smoke hangs over U.S. Skies were looking milky across much of the United States for days as smoke from wildfires raging in Canada drifted into northern and Midwestern states and dipped even as far south as Florida. The Dakotas, Iowa and most of Minnesota and Wisconsin were under air quality alerts, and the haze hung over major cities including New York, Washington, Philadelphia and Boston. More than 200 wildfires were burning in Canada as of June 3, and more than half were classified as "out of control," Canadian forest fire authorities said. More news about our planet: Sign up for USA TODAY's Climate Point newsletter. Trump pardons Florida divers who freed sharks Presidential pardons have often sparked controversy, but Donald Trump's latest gesture had some teeth to it. Trump granted full clemency to two Florida divers, John Moore Jr. and Tanner Mansell, who were convicted of theft for cutting 19 sharks free from a fisherman's longline in 2020. They had assumed the gear was illegal; it turns out it belonged to a vessel permitted by the federal government to harvest sandbar sharks for research. "Whether people believe in his politics or not, he chose to pardon me ... and only ever wanted to help," Mansell said in a text. "I can't help but feel extremely grateful." A fortune sits in 'lost' 401(k) accounts You might think it would be hard to forget almost $60,000. But at least $1.7 trillion is wasting away in forgotten 401(k) accounts, the financial firm Capitalize found, and the average lost balance is $56,616. How does that happen? People who leave a job "usually have a bunch of things going on,' said David John of the AARP Public Policy Institute, and simply lose track. (More than 47 million Americans quit their jobs in the Great Resignation of 2021.) And someone who leaves a job after only a year or two might be especially prone to overlook a modest balance − which, thanks to the magic of tax-free investment growth, eventually turns into a big balance. Loretta Swit, 'M*A*S*H's beloved 'Hot Lips,' dies Fans, friends and co-stars were remembering Loretta Swit, who starred as Major Margaret "Hot Lips" Houlihan through all 11 seasons of TV's hugely popular Korean War dramedy "M*A*S*H" and gave depth and strength to a character who began as an oversexed blond stereotype. Swit, 87, died May 30. "More than acting her part, she created it," star Alan Alda, 89, posted on X. Jamie Farr, 90, who played Corporal Maxwell Q. Klinger, told USA TODAY she was his "adopted sister … as close as family can get." The cast was a tight-knit group through the years, Swit once said: "We might as well be joined at the hip." Close isn't good enough for the New York Knicks Some teams just want to win NOW. Maybe that's why the New York Knicks fired coach Tom Thibodeau, stunning much of the basketball world, just days after the franchise flirted with the NBA Finals for the first time in 25 years before falling to the Indiana Pacers. Not bad for a team that had won just 21 games in the 2019-20 season before Thibodeau took over. The Knicks might be forgiven for being a little impatient after their magical run, however: They have not won a title since 1973. (The NBA Finals, with the Pacers facing the Oklahoma City Thunder, tipped off June 5). − Compiled by Robert Abitbol, USA TODAY copy chief
Yahoo
4 hours ago
- Yahoo
You can now pre-order Pokémon Legends: Z-A for the Switch and Switch 2
Pokémon Legends: Z-A, the much-awaited follow-up to 2022's Pokémon Legends: Arceus, is now available for pre-order. You can get the digital version for the old Switch for $60 or for the new Switch 2 for $70 from Nintendo's website. In case you have no plans to get the Switch 2 anytime soon and you do get the game for the first Switch console, you can purchase an upgrade pack for $10 to get access to better graphics and higher frame rate for Nintendo's new system later on. Pre-ordering lets you pre-load the game so you can play it as soon as it becomes available on October 16. The action role-playing game is not just a follow-up to Arceus, but also a sequel to Pokémon X and Y. It's set in Lumiose City, introduced in X and Y over a decade ago, and features three available starters: Chikorita and Totodile from Gold and Silver, as well as Tepig from Black and White. Its gameplay is a mix of the real-time capture mechanics on Arceus and the old-school turn-based gameplay of traditional Pokémon titles. The game is also bringing back X and Y's Mega Evolution mechanic, which can temporarily transform a Pokémon into a much stronger monster, boosting its power and sometimes even changing its type. The physical version of Pokémon Legends: Z-A is now also available for pre-order from retailers like Walmart (Switch, Switch 2) and Best Buy (Switch, Switch 2.). It's not clear if pre-ordering the game will get you any bonuses, but the Walmart listing URLs hint at an "exclusive gift with purchase."
Yahoo
8 hours ago
- Yahoo
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus
